Who
Peter L. Fishman
SVP, CFO
Company insider
Files Form 4 as: SVP, CFO, Amarin Corporation.
In numbers
- Trades disclosed
- 59
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 10 Jan 2025
- Last trade
- 1 Aug 2026
- Last filed
- 3 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Aug 2026filed 3 Aug 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —313 | filing |
| 1 Aug 2026filed 3 Aug 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $2,210155 at $14.26 | filing |
| 1 Aug 2026filed 3 Aug 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —313 at $0.00 | filing |
| 1 Aug 2026filed 3 Aug 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —313 at $0.00 | filing |
| 1 Aug 2026filed 3 Aug 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —313 | filing |
| 1 Aug 2026filed 3 Aug 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $2,210155 at $14.26 | filing |
| 1 Jul 2026filed 15 Jul 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —2,447 | filing |
| 1 Jul 2026filed 15 Jul 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $19K1,206 at $15.94 | filing |
| 1 Jul 2026filed 15 Jul 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,447 at $0.00 | filing |
| 1 Jul 2026filed 15 Jul 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,447 at $0.00 | filing |
| 1 Jul 2026filed 15 Jul 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —2,447 | filing |
| 1 Jul 2026filed 15 Jul 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $19K1,206 at $15.94 | filing |
| 1 Apr 2026filed 2 Apr 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —125 | filing |
| 1 Apr 2026filed 2 Apr 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $89762 at $14.46 | filing |
| 1 Apr 2026filed 2 Apr 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —125 at $0.00 | filing |
| 1 Apr 2026filed 2 Apr 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —125 at $0.00 | filing |
| 1 Apr 2026filed 2 Apr 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —125 | filing |
| 1 Apr 2026filed 2 Apr 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $89762 at $14.46 | filing |
| 1 Feb 2026filed 3 Feb 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,167 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,750 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.